Table 3.
Risk factors and underlying comorbidities
| Overall | COVID floor admit | COVID ICU admit | Other admit | |
|---|---|---|---|---|
| N | 148 | 111 | 19 | 18 |
| Renal failure (%) | 12 (8.1) | 9 (8.1) | 3 (15.8) | 0 (0.0) |
| Coagulopathy (%) | 5 (3.4) | 3 (2.7) | 0 (0.0) | 2 (11.1) |
| Peptic ulcer disease (%) | 4 (2.7) | 2 (1.8) | 1 (5.3) | 1 (5.6) |
| Liver disease (%) | 1 (0.7) | 1 (0.9) | 0 (0.0) | 0 (0.0) |
| Hypothyroidism (%) | 12 (8.1) | 9 (8.1) | 1 (5.3) | 2 (11.1) |
| Fluid and electrolyte disorders (%) | 2 (1.4) | 2 (1.8) | 0 (0.0) | 0 (0.0) |
| Former smoker (%) | 14 (9.5) | 12 (10.8) | 0 (0.0) | 2 (11.1) |
| Current smoker (%) | 5 (3.4) | 2 (1.8) | 1 (5.3) | 2 (11.1) |
| Vascular disease (%) | 19 (12.8) | 8 (7.2) | 5 (26.3) | 6 (33.3) |
| Pulmonary vascular disorders (%) | 3 (2.0) | 1 (0.9) | 2 (10.5) | 0 (0.0) |
| HIV/AIDS (%) | 2 (1.4) | 2 (1.8) | 0 (0.0) | 0 (0.0) |
| Rheumatic disease (%) | 1 (0.7) | 0 (0.0) | 1 (5.3) | 0 (0.0) |
| Diabetes (%) | 53 (35.8) | 37 (33.3) | 11 (57.9) | 5 (27.8) |
| COPD (%) | 19 (12.8) | 14 (12.6) | 3 (15.8) | 2 (11.1) |
| HTN (%) | 78 (52.7) | 58 (52.3) | 8 (42.1) | 12 (66.7) |
| Anemia (%) | 21 (14.2) | 15 (13.5) | 2 (10.5) | 4 (22.2) |
| Cancer (%) | 16 (10.8) | 9 (8.1) | 2 (10.5) | 5 (27.8) |
| MI (%) | 1 (0.7) | 1 (0.9) | 0 (0.0) | 0 (0.0) |
| CHF (%) | 7 (4.7) | 4 (3.6) | 1 (5.3) | 2 (11.1) |
| Hyperlipidemia (%) | 36 (24.3) | 24 (21.6) | 7 (36.8) | 5 (27.8) |
| Cardiac arrhythmias (%) | 18 (12.2) | 8 (7.2) | 4 (21.1) | 6 (33.3) |
| Dementia (%) | 13 (8.8) | 4 (3.6) | 2 (10.5) | 7 (38.9) |
| Depression (%) | 8 (5.4) | 5 (4.5) | 1 (5.3) | 2 (11.1) |
| Alcohol abuse (%) | 5 (3.4) | 3 (2.7) | 0 (0.0) | 2 (11.1) |
| Drug abuse (%) | 1 (0.7) | 0 (0.0) | 0 (0.0) | 1 (5.6) |
COPD chronic obstructive pulmonary disease, HIV/AIDS human immunodeficiency virus/acquired immune deficiency syndrome, HTN hypertension, MI myocardial infarction, CHF congestive heart failure